Global Self-Monitoring Blood Glucose (SMBG) Devices Market Research Report 2021

Self-monitoring of blood glucose (SMBG) is an important component of modern therapy for diabetes mellitus. SMBG has been recommended for people with diabetes and their health care professionals in order to achieve a specific level of glycemic control and to prevent hypoglycemia. The goal of SMBG is to collect detailed information about blood glucose levels at many time points to enable maintenance of a more constant glucose level by more precise regimens. It can be used to aid in the adjustment of a therapeutic regimen in response to blood glucose values and to help individuals adjust their dietary intake, physical activity, and insulin doses to improve glycemic control on a day-to-day basis.
The classification of self-monitoring blood glucose (SMBG) devices includes strips, glucose meter and lancet. The revenue proportion of strips in 2017 is about 85.08%, and the proportion is in increasing trend from 2013 to 2017.

The global Self-Monitoring Blood Glucose (SMBG) Devices market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Self-Monitoring Blood Glucose (SMBG) Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Self-Monitoring Blood Glucose (SMBG) Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Self-Monitoring Blood Glucose (SMBG) Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Strips
Glucose Meter
Lancet

Segment by Application
Public Hospital
Private Hospital
Clinics
Pharmacy Shops

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Roche
Lifescan
Abbott
Terumo
Ascensia (Bayer)